Form 4 for RLMD RELMADA THERAPEUTICS, INC.
Accepted 2021-07-16 00:00:00 ET · period of report 2021-07-15 · accession 0001213900-21-037273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-07-16 | 2021-07-15 | RLMD | CASAMENTO CHARLES J | Dir | S - Sale | $31.54 | -3,300 | 5,854 | -36% | -$104.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-15 | S | D | 1,164 | $32.49 | 4,700 | D | — | — | (F2) The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. (F4) Sales prices range from $32.32 to $32.93 per share, inclusive |
| 2 | Common | Common Stock | 2021-07-15 | S | D | 2,136 | $31.03 | 5,854 | D | — | — | (F2) The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. (F3) Sales prices range from $30.66 to $31.60 per share, inclusive. |